CVS Stock Ownership Activity

CVS HEALTH CORP 13F holders

4 value investing gurus have made changes to the CVS HEALTH CORP (CVS) position according to the gurus' latest SEC quarterly report(s). The number of CVS shares has been decreased by 4 super investor(s).

Which gurus or hedge funds are buying CVS now?

According to the latest SEC filing(s) CVS HEALTH CORP (CVS) has not been purchased by any super investor.

To see more about who is investing in CVS HEALTH CORP (CVS), please go to the CVS ownership page.

2022 Q2 (4 results)
Ronald Muhlenkamp
-0.10%
-114
-0.00%
4.73%
V. D. Dodge, E. M. Cox
-1.32%
-122,700
-0.01%
1.02%
Robert Olstein
-23.23%
-23,000
-0.32%
1.06%
Prem Watsa
-43.40%
-11,500
-0.04%
0.05%
Current price: $98.58 6.39% AVG reported price*: $92.66
2022 Q1 (4 results)
Ronald Muhlenkamp
+0.37%
+404
+0.01%
3.84%
David Katz
-13.77%
-3,800
-0.58%
3.65%
Mark A. Hillman
-15.58%
-12,000
-0.49%
2.67%
Robert Olstein
-21.43%
-27,000
-0.34%
1.26%
Current price: $98.58 2.60% AVG reported price*: $101.21
2021 Q4 (5 results)
Ronald Muhlenkamp
-0.01%
-12
-0.00%
3.91%
V. D. Dodge, E. M. Cox
-4.43%
-431,000
-0.05%
1.00%
David Katz
-4.83%
-1,400
-0.21%
4.04%
Robert Olstein
-28.81%
-51,000
-0.63%
1.55%
Michael Burry
-100.00%
-200,000
-22.79%
0.00%
Current price: $98.58 4.44% AVG reported price*: $103.16
2021 Q3 (3 results)
Ronald Muhlenkamp
-0.17%
-189
-0.01%
3.54%
Robert Olstein
-1.67%
-3,000
-0.03%
1.84%
James Crichton
-100.00%
-360,000
-1.05%
0.00%
Current price: $98.58 16.17% AVG reported price*: $84.86
2021 Q2 (5 results)
James Crichton
buy
+360,000
+1.01%
0.00%
Michael Burry
+81.82%
+90,000
+5.46%
12.13%
Ronald Muhlenkamp
+0.17%
+189
+0.01%
3.33%
Bruce Berkowitz
-100.00%
-147,000
-0.87%
0.00%
C.T. Fitzpatrick
-100.00%
-8,751
-0.00%
0.00%
Current price: $98.58 18.15% AVG reported price*: $83.44
2021 Q1 (8 results)
Michael Burry
buy
+110,000
+7.11%
7.11%
Bruce Berkowitz
+32.31%
+35,900
+0.22%
0.00%
Mark A. Hillman
+22.22%
+14,000
+0.61%
3.35%
Robert Olstein
+6.51%
+11,000
+0.12%
1.89%
V. D. Dodge, E. M. Cox
+4.95%
+459,600
+0.04%
0.93%
Ronald Muhlenkamp
+0.31%
+334
+0.01%
3.48%
C.T. Fitzpatrick
-99.73%
-3,221,594
-1.43%
0.00%
Bill Miller
-100.00%
-1,899
-0.00%
0.00%
Current price: $98.58 28.31% AVG reported price*: $76.83
2020 Q4 (8 results)
Bruce Berkowitz
buy
+111,100
+0.61%
0.61%
Bill Miller
+40.15%
+544
+0.00%
0.00%
Mark A. Hillman
+26.00%
+13,000
+0.67%
3.26%
C.T. Fitzpatrick
+5.85%
+178,500
+0.08%
1.43%
V. D. Dodge, E. M. Cox
+3.31%
+297,600
+0.03%
0.90%
Robert Olstein
+1.20%
+2,000
+0.02%
1.84%
Ronald Muhlenkamp
+0.79%
+852
+0.02%
2.98%
Michael Burry
-100.00%
-150,000
-6.26%
0.00%
Current price: $98.58 44.29% AVG reported price*: $68.32
2020 Q3 (6 results)
Michael Burry
buy
+150,000
+5.68%
0.00%
Bill Miller
buy
+1,355
+0.00%
0.00%
Mark A. Hillman
+25.00%
+10,000
+0.56%
2.81%
Robert Olstein
+15.97%
+23,000
+0.24%
1.77%
Ronald Muhlenkamp
+0.86%
+911
+0.03%
3.25%
C.T. Fitzpatrick
-30.39%
-1,332,165
-0.61%
1.39%
Current price: $98.58 68.85% AVG reported price*: $58.38
2020 Q2 (4 results)
David Katz
+1.75%
+500
+0.07%
3.91%
Ronald Muhlenkamp
+0.03%
+34
+0.00%
3.70%
C.T. Fitzpatrick
-17.42%
-924,705
-0.47%
2.24%
V. D. Dodge, E. M. Cox
-25.14%
-3,015,400
-0.33%
0.98%
Current price: $98.58 51.73% AVG reported price*: $64.97
47 of 118

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.